Core Competency
Qizheng Tibetan Medicine Wins Two Major Awards: the “Panoramic Investor Relations Gold Award (2022)”
Release time:
2023-05-25 10:37
On May 23, the winners of the 2022 national “Panoramic Investor Relations Gold Award” were officially announced. Qizheng Tibetan Medicine was honored with two prestigious awards: “Best Interaction with Small and Medium-Sized Investors” and “Best New Media Operations.”
It is reported that this ranking was jointly launched by Panorama Network, under the People's Daily, and the China Institute for Corporate Governance at Nankai University. The selection process employed Nankai University’s quantitative evaluation system for “Investor Relations Interactive Communication,” meticulously screening companies from among all A-share listed companies to identify those—both individual companies, individuals, and organizations—that have demonstrated outstanding performance in investor relations efforts. This initiative aims to promote the healthy development of the capital market and enhance the management level of investor relations among Chinese listed companies.
Qizheng Tibetan Medicine places great importance on the interests of investors and regards the protection of small and medium-sized investors as a key guiding principle and crucial approach in its investor relations management. The company prioritizes integrity and compliance with laws and regulations, rigorously ensuring the quality of information disclosure. While providing investors with solid guarantees for their right to know, the company continuously strives to build warm, high-quality interactive relationships with investors.
The company has established a dedicated investor relations hotline and an investor relations email address to promptly respond to various inquiries from investors. We also timely provide answers to investors’ questions about the company’s operations via the “Interactive Easy” platform of the Shenzhen Stock Exchange, covering a wide range of topics including strategy, R&D, finance, products, sales, and fundraising projects. Our responses are sincere and objective, with a 100% response rate. In addition, we proactively hold earnings briefings to create as many opportunities as possible for communication and interaction with our investors, helping them better understand the company’s development strategies and the implementation status of its business plans. This enables investors to make informed investment decisions after gaining a thorough understanding of the company’s fundamentals.
In addition, the company continuously strengthens information sharing and communication with investors through new media platforms such as the official Weibo account of @Qizheng Tibetan Medicine, the “Qizheng Tibetan Medicine Investor Relations Management Platform” WeChat public account, and the “Qizheng Tibetan Medicine Investor Relations” mini-program. The company actively leverages the power of new media to enhance investor relations promotion and management efforts.
Since its launch in 2009, Qizheng Tibetan Medicine has rewarded investors with consistently stable and robust growth in performance, and has distributed cash dividends a total of 13 times, with cumulative cash dividends amounting to 2.116 billion yuan and a dividend payout ratio of 48.43%.
In the future, Qizheng Tibetan Medicine will remain committed to its core values of “acting with kindness and benefiting others, pursuing righteous paths and honest professions, respecting heaven and loving humanity,” and guided by the mission of “promoting health wisdom and creating value in life,” it will become a leading, sustainably developed enterprise spanning the entire Tibetan medicine industry chain, and establish a closed-loop system that delivers long-term value returns to investors.
Previous page
Copyright Qizheng Tibetan Medicine Co., Ltd. All rights reserved. ICP Filing Number:
Internet drug information service qualification certificate number:（藏） Non-Commercial - 2018-0004 SEO